Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL143162 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1ACHETDP1 | |
| Bromide SCHEMBL31058252 | 0.98 | TSHR (0.64) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL31145718 | 0.98 | TSHR (0.64) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL425911 | 0.94 | TSHR (0.59) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL31058260 | 0.92 | TSHR (0.57) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL29457303 | 0.92 | TSHR (0.57) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL8331595 | 0.92 | TSHR (0.57) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL31058126 | 0.92 | TSHR (0.57) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL143163 | 0.91 | TSHR (0.55) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL7583669 | 0.89 | TSHR (0.53) | TSHRLMNAALDH1A1ACHETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260044074-A1 | ACCEPTOR-SUBSTITUTED EUV PAGS WITH HIGH ELECTRON AFFINITY | MERCK PATENT GMBH (DE) | 2026-02-12 | — | — | US | disclosed |
| WO-2024175523-A1 | ACCEPTOR-SUBSTITUTED EUV PAGS WITH HIGH ELECTRON AFFINITY | MERCK PATENT GMBH (DE) | 2024-08-29 | — | — | WO | disclosed |
| CN-111050730-B | Photoinitiator-modified polyacid polymers | 登特斯普伊德特雷有限公司 | 2023-07-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260044074-A1 | ACCEPTOR-SUBSTITUTED EUV PAGS WITH HIGH ELECTRON AFFINITY | ETV6, PAG1, ETV1 | TSHR 368/4885LMNA 1130/4885ALDH1A1 3662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.